Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Karin M. Gilljam"'
Autor:
Nina Richartz, Eva Duthil, Anthony Ford, Elin Hallan Naderi, Sampada Bhagwat, Karin M. Gilljam, Marta Maria Burman, Ellen Ruud, Heidi Kiil Blomhoff, Seham Skah
Publikováno v:
Blood Advances, Vol 3, Iss 21, Pp 3181-3190 (2019)
Abstract: Acute lymphoblastic leukemia (ALL) develops in the bone marrow in the vicinity of stromal cells known to promote tumor development and treatment resistance. We previously showed that the cyclooxygenase (COX) inhibitor indomethacin prevents
Externí odkaz:
https://doaj.org/article/0ca2d37f52d940a795fac60d5a81e428
Autor:
Heidi Kiil Blomhoff, Ellen Ruud, Elin Hallan Naderi, Sampada Bhagwat, Bjørn S. Skålhegg, Seham Skah, Karin M. Gilljam, Wojciech Pietka, Nina Richartz
Supplementary Data from cAMP-Mediated Autophagy Promotes Cell Survival via ROS-Induced Activation of PARP1: Implications for Treatment of Acute Lymphoblastic Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4765f9084a9adb206aeb1c85738d196a
https://doi.org/10.1158/1541-7786.22528074.v1
https://doi.org/10.1158/1541-7786.22528074.v1
Autor:
Heidi Kiil Blomhoff, Ellen Ruud, Elin Hallan Naderi, Sampada Bhagwat, Bjørn S. Skålhegg, Seham Skah, Karin M. Gilljam, Wojciech Pietka, Nina Richartz
DNA-damaging therapy is the basis for treatment of most cancers, including B-cell precursor acute lymphoblastic leukemia (BCP-ALL, hereafter ALL). We have previously shown that cAMP-activating factors present in the bone marrow render ALL cells less
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b1f09c2475a512684bd530de8f8cbc5
https://doi.org/10.1158/1541-7786.c.6545607
https://doi.org/10.1158/1541-7786.c.6545607
Autor:
Nina Richartz, Wojciech Pietka, Karin M. Gilljam, Seham Skah, Bjørn S. Skålhegg, Sampada Bhagwat, Elin Hallan Naderi, Ellen Ruud, Heidi Kiil Blomhoff
Publikováno v:
Molecular Cancer Research. 20:400-411
DNA-damaging therapy is the basis for treatment of most cancers, including B-cell precursor acute lymphoblastic leukemia (BCP-ALL, hereafter ALL). We have previously shown that cAMP-activating factors present in the bone marrow render ALL cells less
Autor:
Karin M Gilljam, Patrik Stenlund, Simon Standoft, Sisse Bindslev Andersen, Kari Kaaber, Henrik Lund, Karl R K Bryn
Publikováno v:
Journal of Burn Care & Research.
Partial-thickness thermal burn wounds are characterized by a prolonged inflammatory response, oxidative stress, tissue damage, and secondary necrosis. An optimal dressing for burn wounds would reduce inflammation and oxidative stress while providing
Autor:
Rebekka Müller, Kristine Misund, Toril Holien, Siri Bachke, Karin M Gilljam, Thea K Våtsveen, Torstein B Rø, Emanuele Bellacchio, Anders Sundan, Marit Otterlei
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e70430 (2013)
Multiple myeloma is a hematological cancer that is considered incurable despite advances in treatment strategy during the last decade. Therapies targeting single pathways are unlikely to succeed due to the heterogeneous nature of the malignancy. Prol
Externí odkaz:
https://doaj.org/article/40105f6515f04da4aa52f22d17571104
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e49199 (2012)
Proliferating cell nuclear antigen (PCNA) is an essential protein for DNA replication, DNA repair, cell cycle regulation, chromatin remodeling, and epigenetics. Many proteins interact with PCNA through the PCNA interacting peptide (PIP)-box or the ne
Externí odkaz:
https://doaj.org/article/b52b6f8714a2438d9bb937049297f075